Security
Pacific Biosciences of California, Inc. Common Stock · PACB
PACBNASDAQCommon stockCurrentCIK 1299130Updated Oct 9, 2026
Name history
PACIFIC BIOSCIENCES OF CALIFORNIA INC · through Feb 5, 2013NANOFLUIDICS INC · through Jul 28, 2004
PACB price & chart
Loading TradingView…
NASDAQ:PACB on TradingView ↗In the news
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference ↗
Recent filings
SCHEDULE 13G/A - filed by ARK Investment Management LLC regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
S-8 filing
10-Q filing
Results of Operations and Financial Condition · Costs Associated with Exit or Disposal Activities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 2.02, 2.05, 5.02, 7.01, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 803,158,000Source | 1,450,052,000Source | 751,850,000Source | 825,470,000Source | 1,509,491,000Source | 782,365,000Source | 860,789,000Source | 1,669,920,000Source | 784,083,000Source | 1,260,447,000Source | 1,746,013,000Source | 1,767,086,000Source |
| Property, Plant and Equipment, NetUSD | 22,127,000Source | 31,952,000Source | 26,972,000Source | 23,102,000Source | 34,910,000Source | 24,376,000Source | 24,794,000Source | 37,291,000Source | 24,146,000Source | 30,505,000Source | 36,432,000Source | 41,580,000Source |
| GoodwillUSD | 317,761,000Source | 369,061,000Source | 317,761,000Source | 317,761,000Source | 369,061,000Source | 317,761,000Source | 317,761,000Source | 462,261,000Source | 317,761,000Source | 317,761,000Source | 462,261,000Source | 409,974,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 16,143,000Source | 436,426,000Source | 13,084,000Source | 17,163,000Source | 443,278,000Source | 14,104,000Source | 18,182,000Source | 450,131,000Source | 15,124,000Source | 389,572,000Source | 456,984,000Source | 410,245,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 56,467,000Source | 77,982,000Source | 61,003,000Source | 54,803,000Source | 99,526,000Source | 56,274,000Source | 58,507,000Source | 76,646,000Source | 63,707,000Source | 55,370,000Source | 179,911,000Source | 325,089,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 30,616,000Source | 29,383,000Source | 31,104,000Source | 32,257,000Source | 32,433,000Source | 29,350,000Source | 31,645,000Source | 30,323,000Source | 35,448,000Source | 27,524,000Source | 36,615,000Source | 18,786,000Source |
| Inventory, NetUSD | 53,153,000Source | 65,737,000Source | 61,084,000Source | 53,839,000Source | 68,594,000Source | 51,022,000Source | 54,007,000Source | 67,343,000Source | 49,285,000Source | 58,755,000Source | 56,676,000Source | 50,381,000Source |
| Assets, CurrentUSD | 394,236,000Source | 584,234,000Source | 338,639,000Source | 413,397,000Source | 628,139,000Source | 369,517,000Source | 444,923,000Source | 677,024,000Source | 375,052,000Source | 495,681,000Source | 742,047,000Source | 852,074,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 11,513,000Source | 17,277,000Source | 9,545,000Source | 12,266,000Source | 16,968,000Source | 13,164,000Source | 15,471,000Source | 17,144,000Source | 10,793,000Source | 18,781,000Source | 17,040,000Source | 10,289,000Source |
| Operating Lease, Right-of-Use AssetUSD | 42,583,000Source | 17,344,000Source | 40,331,000Source | 43,504,000Source | 22,391,000Source | 40,846,000Source | 44,408,000Source | 30,672,000Source | 41,695,000Source | 16,091,000Source | 32,593,000Source | 39,763,000Source |
| Other Assets, NoncurrentUSD | 8,776,000Source | 9,503,000Source | 13,492,000Source | 9,011,000Source | 9,790,000Source | 14,190,000Source | 9,189,000Source | 10,119,000Source | 8,773,000Source | 9,305,000Source | 13,274,000Source | 10,528,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 767,068,000Source | 996,930,000Source | 785,063,000Source | 763,981,000Source | 1,016,791,000Source | 779,999,000Source | 769,151,000Source | 1,020,903,000Source | 778,734,000Source | 753,853,000Source | 1,044,709,000Source | 1,204,182,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 302,000Source | 274,000Source | 311,000Source | 300,000Source | 272,000Source | 311,000Source | 300,000Source | 272,000Source | 302,000Source | 294,000Source | 268,000Source | 227,000Source |
| Additional Paid in CapitalUSD | 2,690,304,000Source | 2,602,592,000Source | 2,715,297,000Source | 2,677,853,000Source | 2,583,523,000Source | 2,705,779,000Source | 2,665,958,000Source | 2,566,304,000Source | 2,699,892,000Source | 2,654,804,000Source | 2,539,892,000Source | 2,099,782,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,654,931,000Source | -2,151,297,000Source | -2,748,318,000Source | -2,616,931,000Source | -2,090,572,000Source | -2,703,577,000Source | -2,575,001,000Source | -1,917,253,000Source | -2,695,302,000Source | -2,148,926,000Source | -1,839,075,000Source | -1,532,340,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 415,000Source | 1,553,000Source | -503,000Source | 267,000Source | -523,000Source | -147,000Source | 381,000Source | -306,000Source | 457,000Source | 422,000Source | 219,000Source | -4,765,000Source |
| Stockholders' Equity Attributable to ParentUSD | 36,090,000Source | 453,122,000Source | -33,213,000Source | 61,489,000Source | 492,700,000Source | 2,366,000Source | 91,638,000Source | 649,017,000Source | 5,349,000Source | 506,594,000Source | 701,304,000Source | 562,904,000Source |
| Liabilities and EquityUSD | 803,158,000Source | 1,450,052,000Source | 751,850,000Source | 825,470,000Source | 1,509,491,000Source | 782,365,000Source | 860,789,000Source | 1,669,920,000Source | 784,083,000Source | 1,260,447,000Source | 1,746,013,000Source | 1,767,086,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 63,209,000Source | 59,997,000Source | 68,806,000Source | 59,754,000Source | 78,390,000Source | 65,355,000Source | 66,602,000Source | 72,951,000Source | 72,831,000Source | 66,299,000Source | 95,029,000Source | 263,335,000Source |
| Operating Lease, Liability, CurrentUSD | 621,000Source | 10,675,000Source | 1,371,000Source | 703,000Source | 12,487,000Source | 277,000Source | 2,417,000Source | 9,772,000Source | 448,000Source | 10,026,000Source | 9,591,000Source | 8,886,000Source |
| Accounts Payable, CurrentUSD | 16,362,000Source | 12,064,000Source | 19,224,000Source | 15,055,000Source | 17,488,000Source | 13,609,000Source | 14,037,000Source | 21,006,000Source | 20,770,000Source | 16,590,000Source | 15,062,000Source | 12,028,000Source |
| Operating Lease, Liability, NoncurrentUSD | 54,300,000Source | 16,933,000Source | 60,424,000Source | 52,082,000Source | 19,620,000Source | 59,004,000Source | 50,480,000Source | 29,049,000Source | 56,592,000Source | 14,914,000Source | 31,606,000Source | 41,070,000Source |
| Other Liabilities, NoncurrentUSD | 0Source | 751,000Source | 8,162,000Source | 0Source | 751,000Source | 7,979,000Source | 0Source | 751,000Source | 0Source | 546,000Source | 751,000Source | 1,300,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 29,172,000Source | 19,183,000Source | 30,322,000Source | 26,541,000Source | 22,456,000Source | 33,904,000Source | 29,337,000Source | 21,991,000Source | 33,646,000Source | 22,595,000Source | 45,708,000Source | 32,596,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 546,000Source | 751,000Source | 835,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 896,683,000Source |
| Short-term InvestmentsUSD | 242,187,000Source | 393,165,000Source | 175,870,000Source | 259,932,000Source | 410,276,000Source | 219,688,000Source | 284,603,000Source | 485,268,000Source | 215,799,000Source | 334,561,000Source | 451,505,000Source | 447,229,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 4,459,000Source | 9,201,000Source | 41,668,000Source | 71,036,000Source | 72,118,000Source | 78,613,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -6,098,000Source | 4,121,000Source | 7,924,000Source | -9,091,000Source | 17,829,000Source | -5,455,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 3,206,000Source | 2,538,000Source | 1,419,000Source | 8,320,000Source | 13,841,000Source | 33,906,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -4,322,000Source | -1,525,000Source | 2,482,000Source | 1,405,000Source | 206,000Source | 1,025,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -546,000Source | -205,000Source | -11,424,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -44,691,000Source | -44,056,000Source | -111,209,000Source | -206,058,000Source | -259,173,000Source | -263,211,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 35,859,000Source | 45,234,000Source | 115,448,000Source | 124,004,000Source | 4,604,000Source | 116,083,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 3,043,000Source | 1,389,000Source | 2,714,000Source | 6,188,000Source | 8,843,000Source | 16,750,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,437,000Source | 1,959,000Source | 3,428,000Source | -42,987,000Source | 108,891,000Source | 9,622,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -7,395,000Source | 3,137,000Source | 7,667,000Source | -125,041,000Source | -145,678,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 58,299,000Source | 80,204,000Source | 62,607,000Source | 56,635,000Source | 57,864,000Source | 60,729,000Source | 65,259,000Source | 57,592,000Source | 182,633,000Source | 328,311,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 8,264,000Source | 14,805,000Source | 15,687,000Source | 14,049,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 481,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | — | — | 369,400,000Source | 27,400,000Source | 8,300,000Source | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | 9,263,000Source | 11,895,000Source | — | — | — | — | 72,118,000Source | 78,613,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 617,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | — | 640,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 1,020,000Source | 366,390,000Source | 369,448,000Source | 27,412,000Source | 6,157,000Source | 900,000Source |
| DepreciationUSD | — | — | — | — | — | — | 2,200,000Source | 5,131,000Source | 12,987,000Source | 13,774,000Source | 11,463,000Source | 9,480,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | -278,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | -2,033,000Source | — |
| GoodwillUSD | — | — | 317,761,000Source | 369,061,000Source | 317,761,000Source | 317,761,000Source | 317,761,000Source | 317,761,000Source | 317,761,000Source | 317,761,000Source | 462,261,000Source | 409,974,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 15,000,000Source | 15,000,000Source | 184,500,000Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | 0Source | — | 0Source | — | 0Source | — | 144,500,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 383,000Source | 0Source | 58,000Source | 35,000Source | 184,000Source | -302,000Source | 318,000Source | 316,000Source | -11,424,000Source | — |
| InterestExpenseNonoperatingUSD | — | — | 1,739,000Source | 3,538,000Source | 2,110,000Source | 1,738,000Source | 1,740,000Source | 1,737,000Source | 6,954,000Source | 13,412,000Source | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 54,000Source | 7,659,000Source | 9,568,000Source | 4,618,000Source | 10,584,000Source | 6,027,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -38,000,000Source | -60,725,000Source | -44,741,000Source | -41,930,000Source | -8,275,000Source | -426,075,000Source | -546,376,000Source | -309,851,000Source | -306,735,000Source | -314,248,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -38,000,000Source | -60,725,000Source | -44,741,000Source | -41,930,000Source | -8,275,000Source | -426,075,000Source | -546,376,000Source | -309,851,000Source | — | — |
| Noncash Merger Related CostsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 3,395,000Source | — |
| Operating ExpensesUSD | — | — | 54,778,000Source | 74,081,000Source | 57,248,000Source | 59,537,000Source | 21,198,000Source | 427,563,000Source | 599,641,000Source | 511,595,000Source | 387,247,000Source | 356,231,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 2,999,000Source | 6,890,000Source | 2,037,000Source | 4,696,000Source | 2,006,000Source | 4,294,000Source | 14,757,000Source | 23,783,000Source | 32,684,000Source | 7,638,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 52,448,000Source | 61,820,000Source | 216,911,000Source | 498,635,000Source | 756,567,000Source | 442,788,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 15,319,000Source | 11,230,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 48,250,000Source | 113,443,000Source | 340,073,000Source | 593,971,000Source | 769,521,000Source | 575,800,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 38,441,000Source | 39,967,000Source | 39,007,000Source | 39,766,000Source | 37,178,000Source | 37,153,000Source | 160,005,000Source | 154,014,000Source | 200,521,000Source | 128,304,000Source |
| Gain (Loss) on Disposition of Assets | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 31,099,000Source | 43,746,000Source | 33,393,000Source | 36,175,000Source | 31,153,000Source | 40,168,000Source | 141,493,000Source | 175,017,000Source | 169,818,000Source | 160,854,000Source |
| Operating Income (Loss)USD | — | — | -38,877,000Source | -64,077,000Source | -44,610,000Source | -44,853,000Source | -8,357,000Source | -428,934,000Source | -553,861,000Source | -474,313,000Source | -334,467,000Source | -307,196,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 2,999,000Source | 6,890,000Source | 2,037,000Source | 4,696,000Source | 2,006,000Source | 4,294,000Source | 14,757,000Source | 23,783,000Source | 32,684,000Source | 7,638,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -37,617,000Source | -60,725,000Source | -44,683,000Source | -41,895,000Source | -8,091,000Source | -426,377,000Source | -546,058,000Source | -309,535,000Source | -318,159,000Source | -314,248,000Source |
| Income Tax Expense (Benefit)USD | — | — | 383,000Source | 0Source | 58,000Source | 35,000Source | 184,000Source | -302,000Source | 318,000Source | 316,000Source | -11,424,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -38,000,000Source | -60,725,000Source | -44,741,000Source | -41,930,000Source | -8,275,000Source | -426,075,000Source | -546,376,000Source | -309,851,000Source | -306,735,000Source | -314,248,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.13Source | -0.22Source | -0.14Source | -0.14Source | -0.03Source | -1.44Source | -1.82Source | -1.13Source | -1.21Source | -1.4Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.13Source | -0.22Source | -0.14Source | -0.14Source | -0.03Source | -1.44Source | -1.82Source | -1.59Source | -1.21Source | -1.4Source |
| Total Revenue | — | — | — | — | — | — | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 300,844,000Source | 272,915,000Source | 310,655,000Source | 300,162,000Source | 305,819,000Source | 296,858,000Source | 299,959,000Source | 274,488,000Source | 253,629,000Source | 224,550,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 300,844,000Source | 272,915,000Source | 310,655,000Source | 300,162,000Source | 305,819,000Source | 296,858,000Source | 299,959,000Source | 288,366,000Source | 253,629,000Source | 224,550,000Source |
| Interest Expense (non-operating)USD | — | — | 1,739,000Source | 3,538,000Source | 2,110,000Source | 1,738,000Source | 1,740,000Source | 1,737,000Source | 6,954,000Source | 13,412,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 1,020,000Source | 366,390,000Source | 369,448,000Source | 27,412,000Source | 6,157,000Source | 900,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | 9,042,000Source | — |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 864,000Source | 521,000Source | 0Source | — |
| Goodwill, Impairment LossUSD | — | — | — | 0Source | — | 0Source | — | 0Source | — | 144,500,000Source | — | — |
| Gross ProfitUSD | — | — | 15,901,000Source | 10,004,000Source | 12,638,000Source | 14,684,000Source | 12,841,000Source | -1,371,000Source | 45,780,000Source | 37,282,000Source | 52,780,000Source | 49,035,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -547,500,000Source | -311,000,000Source | -318,900,000Source | -315,700,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 14,343,000Source | 14,690,000Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 14,117,000Source |
| Investment Income, NetUSD | — | — | 3,100,000Source | 6,000,000Source | 2,200,000Source | 3,400,000Source | 2,500,000Source | 3,900,000Source | 13,100,000Source | 24,900,000Source | 32,800,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -38,000,000Source | -60,725,000Source | -44,741,000Source | -41,930,000Source | -8,275,000Source | -426,075,000Source | -546,376,000Source | -309,851,000Source | — | — |
| Operating ExpensesUSD | — | — | 54,778,000Source | 74,081,000Source | 57,248,000Source | 59,537,000Source | 21,198,000Source | 427,563,000Source | 599,641,000Source | 511,595,000Source | 387,247,000Source | 356,231,000Source |
| Research and Development ExpenseUSD | — | — | 22,846,000Source | 25,516,000Source | 23,022,000Source | 22,529,000Source | 19,608,000Source | 29,053,000Source | 97,307,000Source | 134,922,000Source | 187,170,000Source | 193,000,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 38,441,000Source | 39,967,000Source | 39,007,000Source | 39,766,000Source | 37,178,000Source | 37,153,000Source | 160,005,000Source | 154,014,000Source | 200,521,000Source | 128,304,000Source |
| Total Revenue | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-293751
Filing attachments
tm266949d1_ex4-4.htm · S-3ASR · 2026-02-25
Exhibit 4.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. INDENTURE Dated as of, 20 [__________] Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION 1 BY REFERENCE Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 …
Read attachment ↗tm264755d1_ex99-1.htm · 8-K · 2026-02-02
Exhibit 99.1 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS On January 30, 2026, Pacific Biosciences of California, Inc. (“PacBio” or the “Company” or the “Seller”), completed the disposition of assets to Illumina Cambridge Limited (the “Buyer”), in accordance with the terms of an Asset Purchase Agreement, dated January 30, 2026 (the “Asset Purchase Agreement”), by and between the Company, the Buyer and Illumina, Inc., solely for purposes of Sect…
Read attachment ↗tm264755d1_ex99-2.htm · 8-K · 2026-02-02
Exhibit 99.2 PacBio Completes Sale of Short-Read Sequencing Assets MENLO PARK, Calif., Feb. 2, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash…
Read attachment ↗